AI can double output. Human biology can’t

That policy reflects something larger unfolding across corporate America. Companies are not just using AI to automate tasks. They are using it to raise expectations about how much work humans should produce.

This is not inherently misguided. Measurement is essential to discipline and performance. AI tools can reduce friction, eliminate low-value tasks, and clarify goals. Used thoughtfully, they can enhance human capability.

The mistake lies elsewhere.

The danger emerges when higher measured output is mistaken for sustainable performance. When organizations equate productivity gains with permanent increases in expectation, they effectively borrow against biological reserves. The debt is paid later in disengagement, turnover, and diminished adaptability.

AI can double output. Human biology cannot.

The logic driving escalation is understandable. If generative tools allow a consultant to analyze twice as much data, why not adjust targets? If coding assistants compress development timelines, why not reset delivery schedules? If dashboards quantify performance in real time, why not calibrate expectations with precision?

The problem is that machine acceleration does not automatically expand human capacity.

Human performance follows nonlinear curves. Moderate stress sharpens attention. Chronic stress degrades memory, judgment, and emotional regulation. Energy is finite. Recovery capacity is finite. Emotional bandwidth is finite. When AI increases the pace and volume of work, the biological system does not scale in parallel.

Technology can compress tasks. It cannot compress recovery.

When companies use AI to process twice as much information, attend twice as many meetings, and produce twice as many deliverables, the temptation is to treat that surge as the new baseline. What was once exceptional becomes expected. What was once temporary becomes permanent.

Over time, that mismatch produces predictable consequences. Burnout cycles increase. Absenteeism rises. Creative problem-solving narrows as cognitive load accumulates. Discretionary effort declines. The very tools designed to unlock productivity begin to erode the capacities that sustain it.

These effects carry measurable economic consequences.

Turnover is not a cultural inconvenience. Replacing skilled knowledge workers can cost a significant percentage of annual compensation once recruiting fees, onboarding time, lost productivity, and team disruption are included. If AI-driven expectation resets increase attrition even modestly, the financial gains from higher throughput can be quickly offset by replacement costs and weakened institutional memory.

Productivity volatility also affects earnings quality. Workers operating near physiological limits tend to produce short bursts of elevated output followed by fatigue, disengagement, or extended leave. That volatility complicates planning and weakens operational predictability. In knowledge-intensive industries, sustainable value depends less on raw throughput and more on judgment, innovation, and collaborative problem-solving. Those capabilities degrade when biological constraints are ignored.

The borrowing-against-biological-reserves dynamic resembles financial leverage. When companies increase debt without strengthening underlying cash flow, they amplify short-term returns but raise long-term fragility. Escalating output expectations without reinforcing recovery, autonomy, and trust creates a similar imbalance. Organizations may post impressive quarterly gains while quietly depleting the human capital that supports future performance.

There are also compliance and reputational exposures. As firms collect more behavioral and biometric data through AI systems and wearable technologies, regulators are paying closer attention to privacy and disability protections. A breach involving health or behavioral data can translate quickly into reputational damage and market value erosion. Human capital governance is increasingly part of fiduciary oversight, not a peripheral human resources issue.

None of this suggests abandoning metrics. The distinction lies in how they are used.

AI should remove friction, not permanently raise the biological ceiling. It should expand strategic capacity, not compress recovery time. Metrics can discipline performance, but they cannot eliminate physiological constraints.

Trust plays a decisive role. High-trust environments reduce coordination costs and accelerate execution. When monitoring feels transparent and supportive, adoption tends to follow. When it feels extractive, stress responses increase and intrinsic motivation declines. Surveillance may increase visible output in the short term, but it can quietly raise the long-term cost structure of the organization.

Investors are increasingly scrutinizing workforce stability and resilience as drivers of durable performance. Human capital disclosures now sit alongside financial statements in evaluating long-term value creation. A strategy built on doubling output through AI without reinforcing recovery, autonomy, and trust risks creating brittle organizations that fracture under pressure.

Boards and executive teams should be asking more rigorous questions as AI adoption accelerates. Are productivity gains coming from friction removal or expectation escalation? Are recovery cycles built into performance systems? Are we strengthening human capital durability or consuming it for near-term gains? Over a three- to five-year horizon, which approach produces more stable returns?

The companies most likely to succeed in the AI era will not be those that demand the largest productivity multiples. They will be those that align technological acceleration with biological sustainability.

That requires design discipline. It means building recovery cycles into performance systems. It means measuring value over multi-year horizons rather than rewarding quarterly spikes. And it means recognizing that while AI can expand analytical capacity and compress timelines, it cannot rewrite the limits of human physiology.

Organizations that ignore that constraint may achieve impressive short-term gains. They may also discover that the true bottleneck in the age of artificial intelligence is not technological capability.

It is the biological system expected to keep up with it.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.